共 50 条
The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer
被引:16
作者:
Santos, Luis S.
[1
,2
]
Gomes, Bruno C.
[1
]
Gouveia, Rita
[1
]
Silva, Susana N.
[1
]
Azevedo, Ana P.
[1
,3
]
Camacho, Vanessa
[1
]
Manita, Isabel
[4
]
Gil, Octavia M.
[1
,5
]
Ferreira, Teresa C.
[6
]
Limbert, Edward
[6
]
Rueff, Jose
[1
]
Gaspar, Jorge F.
[1
]
机构:
[1] Univ Nova Lisboa UNL, Fac Med Sci, Dept Genet, P-1349008 Lisbon, Portugal
[2] Univ Catolica Portuguesa UCP, Hlth Sci Inst, Viseu, Portugal
[3] Hosp de S Francisco Xavier, Dept Clin Pathol, Lisbon, Portugal
[4] Hosp Garcia de Orta, Unit Endocrinol, Almada, Portugal
[5] Univ Tecn Lisboa UTL, Unit Radiol Protect & Safety, Inst Super Tecn, Loures, Portugal
[6] Inst Portugues Oncol Lisboa, Dept Nucl Med, Lisbon, Portugal
关键词:
CCNH;
DNA repair;
genetic susceptibility;
nucleotide excision repair;
single nucleotide polymorphisms;
well-differentiated thyroid cancer;
CELL-CYCLE-CONTROL;
DNA-REPAIR;
XPC POLYMORPHISMS;
BLADDER-CANCER;
GENETIC POLYMORPHISMS;
COMMON VARIANTS;
RISK;
ASSOCIATION;
METAANALYSIS;
SMOKING;
D O I:
10.3892/or.2013.2702
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Well-differentiated thyroid cancer (DTC) is the most common form of thyroid cancer (TC); however, with the exception of radiation exposure, its etiology remains largely unknown. Several single nucleotide polymorphisms (SNPs) have previously been implicated in DTC risk. Nucleotide excision repair (NER) polymorphisms, despite having been associated with cancer risk at other locations, have received little attention in the context of thyroid carcinogenesis. In order to evaluate the role of NER pathway SNPs in DTC susceptibility, we performed a case-control study in 106 Caucasian Portuguese DTC patients and 212 matched controls. rs2230641 (CCNH), rs2972388 (CDK7), rs1805329 (RAD23B), rs3212986 (ERCC1), rs1800067 (ERCC4), rs17655, rs2227869 (ERCC5), rs4253211 and rs2228529 (ERCC6) were genotyped using TaqMan (R) methodology, while conventional PCR-RFLP was employed for rs2228000 and rs2228001 (XPC). When considering all DTC cases, only rs2230641 (CCNH) was associated with DTC risk; a consistent increase in overall DTC risk was observed for both the heterozygous genotype (OR=1.89, 95% CI=1.14-3.14) and the variant allele carriers (OR=1.79, 95% CI=1.09-2.93). Histological stratification analysis confirmed an identical effect on follicular TC (OR=2.72, 95% CI=1.19-6.22, for heterozygous; OR=2.44, 95% CI=1.07-5.55, for variant allele carriers). Considering papillary TC, the rs2228001 (XPC) variant genotype was associated with increased risk (OR=2.33, 95% CI=1.05-5.16), while a protective effect was observed for rs2227869 (ERCC5) (OR=0.26, 95% CI=0.08-0.90, for heterozygous; OR=0.25, 95% CI=0.07-0.86, for variant allele carriers). No further significant results were observed. Our results suggest that NER polymorphisms such as rs2230641 (CCNH) and, possibly, rs2227869 (ERCC5) and rs2228001 (XPC), may influence DTC susceptibility. However, larger studies are required to confirm these results.
引用
收藏
页码:2458 / 2466
页数:9
相关论文